Tasurgratinib
5-[[2-[[4-[1-(2-hydroxyethyl)piperidin-4-yl]benzoyl]amino]-4-pyridinyl]oxy]-6-(2-methoxyethoxy)-N-methylindole-1-carboxamide
Molecular Identity
Tasurgratinib
5-[[2-[[4-[1-(2-hydroxyethyl)piperidin-4-yl]benzoyl]amino]-4-pyridinyl]oxy]-6-(2-methoxyethoxy)-N-methylindole-1-carboxamide
PubChem CID: 78323434
2D Structure
Properties
C32H37N5O6
Molecular Formula
587.70
Molecular Weight
g/mol
587.2744
Exact Mass
Da
3.1
XLogP
Drug-like (Lipinski: < 5)
127
TPSA
Good oral absorption (< 140 A²)
3
H-Bond Donors
8
H-Bond Acceptors
880
Complexity
SMILES
Canonical SMILES
SMILES: CNC(=O)N1C=CC2=CC(=C(C=C21)OCCOC)OC3=CC(=NC=C3)NC(=O)C4=CC=C(C=C4)C5CCN(CC5)CCOIsomeric SMILES
SMILES: CNC(=O)N1C=CC2=CC(=C(C=C21)OCCOC)OC3=CC(=NC=C3)NC(=O)C4=CC=C(C=C4)C5CCN(CC5)CCOSynonyms(20)
E-7090tasurgratinibTN7CUD1NGAUNII-TN7CUD1NGATASURGRATINIB [INN]E 7090Tasurgratinib (INN)5-[2-[[4-[1-(2-hydroxyethyl)piperidin-4-yl]benzoyl]amino]pyridin-4-yl]oxy-6-(2-methoxyethoxy)-N-methylindole-1-carboxamideExample 22 [WO2014129477A1]Example 22 (WO2014129477A1)5-(2-((4-(1-(2-hydroxyethyl)piperidin-4-yl)benzoyl)amino)pyridin-4-yl)oxy-6-(2-methoxyethoxy)-N-methylindole-1-carboxamideRefChem:187502E-7090 [WHO-DD]1-(2-HYDROXYETHYL)-7-(2-METHOXYETHOXY)-N-METHYL-3-OXO-7H-6-OXA-4-AZA-7(5)-INDOLA-5(2,4)-PYRIDINA-1(4)-PIPERIDINA-2(1,4)-BENZENAHEPTAPHANE-7-CARBOXAMIDE1622204-21-0
Data from PubChem (NCBI)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Drug Network
Trials and conditions connected to Tasurgratinib
Loading drug network...